Centrus Taps Fluor For Major Ohio Uranium Expansion Amid Nuclear Fuel Push

Centrus said its subsidiary, American Centrifuge Operating LLC, signed a long-term agreement with Fluor to handle engineering, procurement, and construction work tied to the capacity buildout in Piketon, Ohio.
In this photo illustration, a person holds a smartphone displaying the logo of Centrus Energy Corp.
In this photo illustration, a person holds a smartphone displaying the logo of Centrus Energy Corp.(Photo illustration by Cheng Xin/Getty Images)
Profile Image
Shivani Kumaresan·Stocktwits
Updated Feb 11, 2026   |   8:29 AM EST
Share
·
Add us onAdd us on Google
  • Fluor will oversee plant design, sourcing of materials, on-site construction, and final commissioning of the upgraded facilities.
  • Centrus plans to produce 12 metric tons per year of high-assay, low-enriched uranium (HALEU) to supply next-generation nuclear reactors. 
  • For 2026, the company plans a capital expenditure in the range of $350 million to $500 million.

Centrus Energy Corp. (LEU) on Wednesday named Fluor Corp. (FLR) as the engineering and construction lead for the expansion of its uranium enrichment operations in Ohio.

The move marks an important step in Centrus’ effort to scale domestic nuclear fuel production amid rising demand.

Strategic Partnership

Centrus said its subsidiary, American Centrifuge Operating LLC, signed a long-term agreement with Fluor to handle engineering, procurement, and construction work tied to the capacity buildout in Piketon, Ohio. 

Fluor will oversee plant design, sourcing of materials, on-site construction, and final commissioning of the upgraded facilities.

Following the announcement, Centrus Energy stock traded over 7% lower in Wednesday’s premarket. On Stocktwits, retail sentiment around the stock remained in ‘bearish’ territory while message volume shifted to ‘extremely high’ from ‘normal’ levels in 24 hours. 

Expanding Enrichment Capacity

The Ohio project aims to significantly increase the output of low-enriched uranium, or LEU, as Centrus works through a commercial backlog valued at approximately $2.3 billion. The company also plans to produce 12 metric tons per year of high-assay, low-enriched uranium (HALEU) to supply next-generation nuclear reactors. 

Momentum behind the expansion picked up late last year. In December 2025, Centrus began manufacturing centrifuges to support higher production levels. In early January 2026, the Department of Energy awarded the company a $900 million task order focused on HALEU.

In 2026, the company plans a capital expenditure in the range of $350 million to $500 million and expects revenue between $425 million and $475 million. 

LEU stock has gained over 9% in the last 12 months. 

Also See: MAT Shares Sink After Earnings Miss Spurs Dual Wall Street Downgrades

For updates and corrections, email newsroom[at]stocktwits[dot]com.

Share
·
Add us onAdd us on Google
Read about our editorial guidelines and ethics policy